The platform allows scientists to quickly identify, produce, and test products encoded by genomes of organisms that are not easily grown in the lab. Radiant Genomics was acquired by Zymergen in 2018 and possessed a large catalog of genetic diversity. Zymergen will use Radiant's technologies for commercialization of novel molecules in agriculture, healthcare, and chemicals.